FDA Approved Medical Products for:

Laron syndrome

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Mecasermin
Trade Name
(Manufacturer Name)
Increlex®
(Tercica, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Long-term treatment of growth failure in children with severe primary IGF-1 deficiency (Primary IGFD) or with growth hormone (GH) gene deletion who have developed neutralizing antibodies to growth hormone.
More Information about this product Drug Information Portal

Generic Name Mecasermin rinfabate
Trade Name
(Manufacturer Name)
Iplex®
(Insmed, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of growth failure in children with severe primary IGF-1 deficiency (Primary IGFD) or with growth hormone (GH) gene deletion who have developed neutralizing antibodies to growth hormone
More Information about this product Drug Information Portal